Medication info

Megafor 10/160 mg

Prescription medicationExpired
Ingredient · strength
Valsartan›Strength being verifiedAmlodipine Besylate›Strength being verified
Manufacturer / importer
(株)Handok
Appearance
Bright yellow egg-shaped film-coated tablets
Packaging
28 tablets (14 tablets/PTP packaging X 2), 30 tablets/bottle
Approval status
Expired

MFDS item code 201309058 · Approved 2013.08.29

This product's status changed to Expired on 2023.08.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who uses it
Adults · Children
Adult dosage
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, switching directly to this medication may be considered if blood pressure is not adequately controlled with monotherapy using either component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Children's dosage
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
(株)Handok

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or valsartan.

Dosage and Administration

Adult dosage

The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, switching directly to this medication may be considered if blood pressure is not adequately controlled with monotherapy using either component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Children's dosage

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication may cause serious harm to the fetus or newborn if taken during the second or third trimester of pregnancy; it should be discontinued immediately once pregnancy is confirmed. It should not be used in patients with an allergy to the active ingredients or similar drug classes, women who are pregnant or breastfeeding, patients with severe kidney or liver disease, or patients with certain heart conditions. Patients who are deficient in sodium or fluid must manage their condition before taking this medication, and if symptoms of hypotension appear, they should be laid down immediately and may require fluid therapy. Patients with high potassium levels should take caution when taking this drug and potassium-increasing medications together, and potassium levels should be monitored frequently. Patients with renal artery stenosis or those who have recently undergone kidney transplantation should use this medication with caution, as it may affect kidney function. If symptoms of angioedema occur, use of the medication should be discontinued immediately, and it should not be readministered. Patients with heart failure or after myocardial infarction should be carefully monitored for changes in kidney function when taking this medication, and it is advisable not to combine it with certain drugs in heart failure patients. This medication may cause various adverse reactions, with common symptoms including headache, dizziness, swelling, fatigue, etc. Caution should be exercised when driving or operating machinery, as dizziness or fatigue may occur. When used in combination with other medications, there may be interactions, so consultation with a doctor or pharmacist is necessary, especially when used with certain antihypertensives, potassium supplements, or specific anti-inflammatory medications. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid its use. It is not recommended for children under 18 years of age, as safety and effectiveness have not been sufficiently established. Elderly patients may use similar dosages as adults, but their physical status should be closely monitored. Overdosage may lead to severe hypotension or cardiovascular abnormalities, requiring immediate medical attention. During treatment, it is important to regularly check blood pressure, kidney function, and electrolyte levels.

Side effects

  • Pharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • positional dizziness
  • paresthesia
Show 109 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • oropharyngeal and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasm
  • lethargy
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • localized swelling
  • facial swelling
  • peripheral edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • hyperkalemia
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • renal damage
  • elevated serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory impairment
  • taste disturbance
  • peripheral neuropathy
  • muscle rigidity
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • dysuria
  • enuresis
  • gynecomastia
  • pain
  • lethargy
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • chest pain
  • weight gain
  • arthralgia
  • musculoskeletal pain
  • rhabdomyolysis
  • gingival polyposis
  • gastritis
  • neuroexcitability
  • sensory impairment
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Bright yellow egg-shaped film-coated tablets

Package unit

28 tablets (14 tablets/PTP packaging X 2), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.